DeepHealth develops AI-powered health informatics for radiology, working across the full continuum of the field - from disease detection and assessment to monitoring and treatment planning. The company is a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and operates globally, with its technology deployed at more than 300 sites worldwide.
Its technical work spans artificial intelligence, medical imaging, cloud-native software, radiology workflow automation and population health analytics. Central to this is DeepHealth OS, a cloud-native operating system designed to unify data across clinical and operational workflows and to personalise AI-powered workspaces for participants in the radiology ecosystem. Around it sit an Enterprise Imaging category - comprising the Diagnostic Suite, Operations Suite and TechLive - and Population Health suites covering breast, prostate, chest/thyroid and neuro imaging.
DeepHealth also develops FDA-cleared AI applications. Its population health tooling supports more than 10 million mammograms annually, and the company reports a 21% increase in breast cancer detection rates in landmark studies published in Nature Health.
